129 related articles for article (PubMed ID: 12518342)
1. Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings.
Halonen P; Mattila J; Ruuska T; Salo MK; Mäkipernaa A
Med Pediatr Oncol; 2003 Mar; 40(3):148-54. PubMed ID: 12518342
[TBL] [Abstract][Full Text] [Related]
2. Low-dose steroids associated with milder histological changes after pediatric liver transplantation.
Kosola S; Lampela H; Jalanko H; Mäkisalo H; Lohi J; Arola J; Pakarinen MP
Liver Transpl; 2013 Feb; 19(2):145-54. PubMed ID: 23109058
[TBL] [Abstract][Full Text] [Related]
3. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
5. Prolylhydroxylase and procollagen type III in long-term survivors of acute lymphoblastic leukemia (ALL): a biochemical approach to HCV-related liver disease.
Leonardi S; La Spina M; La Rosa M; Schilirò G
Med Pediatr Oncol; 2003 Jul; 41(1):17-20. PubMed ID: 12764737
[TBL] [Abstract][Full Text] [Related]
6. [The role of ultrasonography in the diagnosis of diffuse liver disease].
Berrut C; Curati W; de Gautard R; Widmann JJ; Godin N; Loizeau E
Schweiz Med Wochenschr; 1986 Feb; 116(7):215-8. PubMed ID: 3513304
[TBL] [Abstract][Full Text] [Related]
7. High-dose methotrexate administration and acute liver damage in children treated for acute lymphoblastic leukemia. A prospective study.
Locasciulli A; Mura R; Fraschini D; Gornati G; Scovena E; Gervasoni A; Uderzo C; Masera G
Haematologica; 1992; 77(1):49-53. PubMed ID: 1398282
[TBL] [Abstract][Full Text] [Related]
8. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy associated hepatotoxicity in the treatment of advanced colorectal cancer (CRC)].
Tannapfel A; Reinacher-Schick A
Z Gastroenterol; 2008 May; 46(5):435-40. PubMed ID: 18461519
[TBL] [Abstract][Full Text] [Related]
10. Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection.
Perumalswami P; Kleiner DE; Lutchman G; Heller T; Borg B; Park Y; Liang TJ; Hoofnagle JH; Ghany MG
Hepatology; 2006 Apr; 43(4):780-7. PubMed ID: 16557550
[TBL] [Abstract][Full Text] [Related]
11. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
12. Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
McPherson S; Anstee QM; Henderson E; Day CP; Burt AD
Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):652-8. PubMed ID: 23325287
[TBL] [Abstract][Full Text] [Related]
13. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
Stránský J; Ryzlová M; Striteský J; Horák J
Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
[TBL] [Abstract][Full Text] [Related]
14. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
Mofrad P; Contos MJ; Haque M; Sargeant C; Fisher RA; Luketic VA; Sterling RK; Shiffman ML; Stravitz RT; Sanyal AJ
Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Verma S; Jensen D; Hart J; Mohanty SR
Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum transaminase values during therapy for acute lymphoblastic leukemia correlate with prior blood transfusions.
Hetherington ML; Buchanan GR
Cancer; 1988 Oct; 62(8):1614-8. PubMed ID: 3139278
[TBL] [Abstract][Full Text] [Related]
17. Hepatotoxicity in the treatment of acute lymphoblastic leukaemia.
Topley JM; Benson J; Squier MV; Chessells JM
Med Pediatr Oncol; 1979; 7(4):393-9. PubMed ID: 296787
[TBL] [Abstract][Full Text] [Related]
18. [Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B].
Chen XB; Zhu X; Chen LY; Chen EQ; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):286-90. PubMed ID: 21586228
[TBL] [Abstract][Full Text] [Related]
19. Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases.
Suzuki Y; Yokoyama A; Nakano M; Okuyama K; Takahashi H; Tamai H; Maruyama K; Ishii H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):100S-105S. PubMed ID: 10803790
[TBL] [Abstract][Full Text] [Related]
20. Fatty liver and its fibrous changes found in simple obesity of children.
Kinugasa A; Tsunamoto K; Furukawa N; Sawada T; Kusunoki T; Shimada N
J Pediatr Gastroenterol Nutr; 1984 Jun; 3(3):408-14. PubMed ID: 6737186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
